Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer

Bull Cancer. 2024 Mar 7:S0007-4551(24)00046-8. doi: 10.1016/j.bulcan.2023.12.011. Online ahead of print.NO ABSTRACTPMID:38458926 | DOI:10.1016/j.bulcan.2023.12.011

Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Hanna Besnainou Luc Cabel Source Type: research